Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations (Tables)

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2012

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]



	September 30, 2012		December 31, 2011
Current assets	$	198	$	1,013
Non-current assets	475		625
Total assets	$	673	$	1,638
Current liabilities	$	508	$	1,865
Non-current liabilities	1,232		1,526
Total liabilities	$	1,740	$	3,391



	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2012			2011			2012			2011
Revenue, net	$	—		$	1,178		$	—		$	4,966
(Loss) income from discontinued operations, before income tax	(188		)	(165		)	(200		)	55
Provision (benefit) for income tax	1			1			4			(172		)
(Loss) income from discontinued operations, net of tax	$	(189	)	$	(166	)	$	(204	)	$	227

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details